Raymond James & Associates’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,158
Closed -$291K 4213
2021
Q2
$291K Sell
4,158
-2,235
-35% -$162K ﹤0.01% 3459
2021
Q1
$498K Buy
+6,393
New +$452K ﹤0.01% 3029
2019
Q4
Sell
-8,761
Closed -$717K 3721
2019
Q3
$717K Buy
8,761
+60
+0.7% +$4.97K ﹤0.01% 2399
2019
Q2
$706K Buy
8,701
+204
+2% +$15.7K ﹤0.01% 2426
2019
Q1
$645K Buy
8,497
+358
+4% +$28.4K ﹤0.01% 2493
2018
Q4
$639K Buy
8,139
+1,416
+21% +$111K ﹤0.01% 2379
2018
Q3
$507K Buy
+6,723
New +$495K ﹤0.01% 2701

Other funds holding NHC

Raymond James & Associates's NHC Position: Q3 2021 in Review

Raymond James & Associates sold out of National Healthcare (NHC) in Q3 2021, closing a stake of 4,158 shares — an estimated $291K sold.

Raymond James & Associates first reported a position in NHC in Q3 2018 and held it in 7 quarters. The position peaked at $717K in Q3 2019. 129 funds tracked by Wall St. Rank hold NHC as of Q3 2021.

  • Raymond James & Associates reported no remaining National Healthcare position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 4,158 National Healthcare shares in Q3 2021, an estimated $291K.
  • Raymond James & Associates first reported a position in National Healthcare in Q3 2018 and held it in 7 quarters.
  • Raymond James & Associates's National Healthcare position peaked at $717K in Q3 2019.
  • 129 funds tracked by Wall St. Rank held National Healthcare as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.